—
C+
C+ The full Closelook — membership. Open the C+ overview

Fisher & Paykel Healthcare Corporation Ltd (FPH.AU) — chart, structure and Closelook read

Home› Indices›
Pick a ticker to load its detail page.

Company snapshot — Fisher & Paykel Healthcare Corporation Ltd

FPH.AU in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Fisher & Paykel Healthcare designs and sells medical devices for respiratory care, surgery and obstructive sleep apnoea treatment, sold to hospitals and used at home. Its adult and infant respiratory lines cover ventilation support, humidification and nasal high-flow therapy, while its homecare range includes CPAP devices, masks and data-management software. Founded in 1934, it is based in Auckland, New Zealand, and sells into North America, Europe and the Asia Pacific.
Where it sits in the stack
The company sits outside the diary's AI build-out coverage; it belongs to the Healthcare sector within our wider universe, in the Medical Instruments & Supplies industry, and carries no seat in our index.
Who it is priced against
Closelook groups it with other scored Healthcare names for comparison — argenx, Eli Lilly, Medpace, BeiGene, UCB, Globus Medical and Regeneron; the market also names ResMed as a direct competitor in respiratory and sleep-therapy devices.
Why Closelook tracks it
It carries a Closelook score, our multi-module read of a stock; momentum is its strongest module and valuation its weakest. It holds no seat in our index and the diary has not yet quoted it in an edition.
What the diary watches
Whether the valuation module narrows against its stronger momentum reading, and whether growth in home-use respiratory devices keeps pace with the hospital side of the business.

Fisher & Paykel Healthcare Corporation Ltd (FPH.AU) trades on the AU exchange in Australia.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for FPH.AU, from the same nightly bakes the boards use. Research diary readings, not advice.

Who it is priced against Medical Instruments & Supplies · 8 names with week and year-to-date

Peer group

Medical Instruments & Supplies

This name carries no Closelook score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against FPH.AU on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Dividends and capital return trailing yield 1.24%, semi-annual · last 0.27 AUD on 2026-06-22

Dividends and capital return

What FPH.AU pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 0.44 AUD per share · a 1.24% yield on the 2026-09-18 close 2 distributions, paid twice a year 2026-09-18
  • Change on the year +95.5% against the prior twelve months prior twelve months 0.22 AUD per share
  • Last distribution 0.27 AUD per share as the price series records it, within days of the ex-date 2026-06-22
  • By calendar year 2025: 0.39 AUD (partial) · 2026: 0.27 AUD to date first distribution recorded in the three-year window: 2025-06-23

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 50/100 · S&P 500 fund at 49, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-18
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 97th percentile of the window, +4.9% over 20 sessions. Factor regime → 2026-09-18
  • Sovereign pressure Index 0.07 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-18

FAQ · from the current data · as of 2026-09-19

Quick answers

What is Fisher & Paykel Healthcare Corporation Ltd (FPH.AU)?

Fisher & Paykel Healthcare Corporation Ltd trades as FPH.AU on the AU exchange (Australia) in the Closelook research universe, as of the registry build of 2026-09-19.

Is FPH.AU in a Closelook index?

Not currently — Fisher & Paykel Healthcare Corporation Ltd is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-19.

Where does FPH.AU trade against its moving averages?

Uptrend stack intact: Trades +0.6% vs the 50-day and +8.9% vs the 200-day average, 6.6% below the 52-week high and +34% off the 52-week low; a golden cross printed 37 sessions ago. Computed from daily closes. As of 2026-09-18 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

What does Fisher & Paykel Healthcare Corporation Ltd do?

Fisher & Paykel Healthcare designs and sells medical devices for respiratory care, surgery and obstructive sleep apnoea treatment, sold to hospitals and used at home. Its adult and infant respiratory lines cover ventilation support, humidification and nasal high-flow therapy, while its homecare range includes CPAP devices, masks and data-management software. Founded in 1934, it is based in Auckland, New Zealand, and sells into North America, Europe and the Asia Pacific. Closelook groups it with other scored Healthcare names for comparison — argenx, Eli Lilly, Medpace, BeiGene, UCB, Globus Medical and Regeneron; the market also names ResMed as a direct competitor in respiratory and sleep-therapy devices.

Where does Fisher & Paykel Healthcare Corporation Ltd sit in the AI build-out?

The company sits outside the diary's AI build-out coverage; it belongs to the Healthcare sector within our wider universe, in the Medical Instruments & Supplies industry, and carries no seat in our index. It carries a Closelook score, our multi-module read of a stock; momentum is its strongest module and valuation its weakest. It holds no seat in our index and the diary has not yet quoted it in an edition.

Does Fisher & Paykel Healthcare Corporation Ltd pay a dividend?

Fisher & Paykel Healthcare Corporation Ltd has paid 0.44 AUD per share over the last twelve months, paid twice a year, a trailing yield of 1.24% on the 2026-09-18 close; the last distribution recorded in the price series was 0.27 AUD on 2026-06-22. The "Dividends and capital return" block on this page carries the lines.

What does this page show?

A live price chart with SMA overlays and drawing tools for FPH.AU, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe

then Medical Instruments & Supplies. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.